Clinical Trials Directory

Trials / Completed

CompletedNCT00702026

The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients

The Effect of a Multispecies Probiotic on Hypersensitivity in IBS Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a specifically designed multispecies probiotic decreases visceral hypersensitivity in IBS-patient (defined by an increased pain tolerance threshold). Moreover, the effect on general symptom scores and inflammatory and microbiological parameters will be studied.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTmultispecies probiotic (Ecologic 801)once daily, 5 gram \[10e9 cfu/gram\]
DIETARY_SUPPLEMENTPlaceboonce daily, 5 gram \[10e9 cfu/gram\]

Timeline

Start date
2008-08-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2008-06-19
Last updated
2013-01-29

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00702026. Inclusion in this directory is not an endorsement.